Mast Cell Activation Syndrome
(asked on 23rd February 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of allowing the use of off-label medications in the treatment of Mast Cell Activation Syndrome.
This question was answered on 28th February 2018
We have made no such assessment. Prescribers are able to use medicinal products outside their licensed indications where they are satisfied that they best meet the individual clinical needs of their patient. This is part and parcel of normal clinical practice.